1.Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases
Ryu Sun Kwang ; Park Woo Hyun ; Park Ho Soo ; Shon Sun Ho ; Ryu Ho Keun ; Lee Gyu Dong ; Bashir EA Mohamed ; Lee Hee Ju ; Kim Min Sang ; Lee Yeub Sang ; Bae Whan Jang ; Hwang Kuk Kyung ; Kim Woon Dong ; Cho Chan Myeong ; Ahn Keun Young ; Jeong Ho Myung ; Kim Jin Chong ; P
Journal of Geriatric Cardiology 2015;(3):208-217
Background The clinical significance of complete revascularization for ST segment elevation myocardial infarction (STEMI) pa-tients during admission is still debatable. Methods A total of 1406 STEMI patients from the Korean Myocardial Infarction Registry with multivessel diseases without cardiogenic shock who underwent primary percutaneous coronary intervention (PPCI) were analyzed. We used propensity score matching (PSM) to control differences of baseline characteristics between culprit only intervention (CP) and multivessel percutaneous coronary interventions (MP), and between double vessel disease (DVD) and triple vessel disease (TVD). The major adverse cardiac event (MACE) was analyzed for one year after discharge. Results TVD patients showed higher incidence of MACE (14.2%vs. 8.6%, P=0.01), any cause of revascularization (10.6%vs. 5.9%, P=0.01), and repeated PCI (9.5%vs. 5.7%, P=0.02), as compared to DVD patients during one year after discharge. MP reduced MACE effectively (7.3%vs. 13.8%, P=0.03), as compared to CP for one year, but all cause of death (1.6%vs. 3.2%, P=0.38), MI (0.4%vs. 0.8%, P=1.00), and any cause of revascularization (5.3%vs. 9.7%, P=0.09) were comparable in the two treatment groups. Conclusions STEMI patients with TVD showed higher rate of MACE, as compared to DVD. MP performed during PPCI or ad hoc during admission for STEMI patients without cardiogenic shock showed lower rate of MACE in this large scaled database. Therefore, MP could be considered as an effective treatment option for STEMI patients without cardiogenic shock.
2.The Prevalence of Obesity and Metabolic Abnormalities in Korean Pediatric Population.
Han Nae NHO ; Cu Rie KIM ; Ji Hyun UHM ; Jeong Tae KIM ; Sun Mi JIN ; Ji Young SEO ; Hye Won HAHN ; Hwa Young PARK ; Hye Sun YOON ; Young Min AHN ; Keun Chan SHON
Korean Journal of Pediatric Gastroenterology and Nutrition 2009;12(2):207-214
PURPOSE: Childhood obesity can be complicated by hypertension, hyperlipidemia, non-alcoholic fatty liver disease, and diabetes mellitus. The aim of this study was to evaluate the prevalence of obesity and metabolic complications of children and adolescents based on the degree of obesity. METHODS: We analyzed the records of 8,880 students who received student health examinations between May 2006 and October 2008 at the Eulji General Hospital. The prevalence of obesity was evaluated by the body mass index and obesity index. A total of 1,076 obese students had blood tests. We analyzed aspartate aminotransferase (AST), alanine aminotransferase (ALT), fasting glucose, total cholesterol, and blood pressure according to the degree of obesity. RESULTS: According to the body mass index, the overall prevalence of obesity was 7.2% (7.8% of male and 6.5% of female students). Based on the obesity index, 12.3% of students (mild: 6.3%, moderate: 5.0%, and severe: 1.0%) were obese. The prevalence of hypercholesterolemia, ALT elevation, and hypertension were increased as a function of the degree of obesity (p<0.05), but hyperglycemia showed no significant differences (p=0.298). The overall prevalence of ALT elevation was 17.7% (mild obese group, 10.4%; moderate obese group, 20.5%; and severe obese group, 46.8%). The prevalence of hypercholesterolemia, hypertension, and hyperglycemia were significantly higher in the elevated ALT group (24.7%, 42.6%, and 5.2%, respectively) compared to the normal ALT group (11.1%, 29.8%, and 2.0%, respectively; p<0.05). CONCLUSION: Hypercholesterolemia, liver function test abnormalities, and hypertension were associated with the degree of obesity. We should focus our attention on managing obese children and adolescents to prevent metabolic complications.
Adolescent
;
Alanine Transaminase
;
Aspartate Aminotransferases
;
Blood Pressure
;
Body Mass Index
;
Child
;
Cholesterol
;
Diabetes Mellitus
;
Fasting
;
Fatty Liver
;
Female
;
Glucose
;
Hematologic Tests
;
Hospitals, General
;
Humans
;
Hypercholesterolemia
;
Hyperglycemia
;
Hyperlipidemias
;
Hypertension
;
Liver Function Tests
;
Male
;
Obesity
;
Prevalence